Loading...
ROS-activated anticancer prodrugs: a new strategy for tumor-specific damage
Targeting tumor cells is an important strategy to improve the selectivity of cancer therapies. With the advanced studies in cancer biology, we know that cancer cells are usually under increased oxidative stress. The high level of reactive oxygen species in cancer cells has been exploited for develop...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2012
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3566582/ https://ncbi.nlm.nih.gov/pubmed/22900465 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|